Status:
COMPLETED
Depot Medroxyprogesterone Acetate as Emergency Contraception
Lead Sponsor:
University of Southern California
Collaborating Sponsors:
Society of Family Planning
Conditions:
Emergency Contraception
Contraception
Eligibility:
FEMALE
18-39 years
Phase:
EARLY_PHASE1
Brief Summary
Background: The prevalence of repeat unprotected intercourse after EC use in the same cycle demonstrate the need for more self-bridging emergency contraceptive options. We propose the use of intramus...
Detailed Description
The proposed study will enroll 36 healthy, non-pregnant, non-breastfeeding, reproductive age women with regular ovulatory cycles. Potential participants will undergo screening, which will include a hi...
Eligibility Criteria
Inclusion
- Healthy women of reproductive age (18-39 years old) with BMI 18-30 kg/m2
- Regular menses for the last 3 months
- Cycle duration 24 to 35 days
- Women using copper IUD, sterilization, or barrier methods as current or preferred birth control method, and women reporting exclusive sex with women
- English- or Spanish-speaking
Exclusion
- Any contraindications to progesterone contraception per teh CDC Medical Eligibility Criteria (Category 3 or 4)
- On medications that can alter, or be altered by, progesterone contraceptive steroid hormone (e.g., aminoglutethimide or other anti-steroid medication)
- Use of any hormonal contraceptive pill, patch, or vaginal ring in the month prior to recruitment
- Use of depot-medroxyprogesterone acetate in teh 10 months prior to recruitment
- Currently pregnant and/or breastfeeding
- History of allergic reaction to depot medroxyprogesterone acetate (rash, urticaria, anaphylaxis)
Key Trial Info
Start Date :
August 31 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 30 2020
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03395756
Start Date
August 31 2018
End Date
October 30 2020
Last Update
November 5 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Southern California Keck Medical Center
Los Angeles, California, United States, 90033